INTELLIA THERAPEUTICS INC (NTLA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NTLA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NTLA | [] | [] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Goodman served on the nominating and corporate governance committee throughout 2025 and on the science and technology committee throughout 2025, serving as committee chair of the science and technology committee. Our board of directors has determined that Dr. Goodman is independent as defined in the applicable Nasdaq rules.